Home / Paid / SGLT-2 Inhibitors’ Association with Fournier Gangrene

SGLT-2 Inhibitors’ Association with Fournier Gangrene

Dec 10, 2019
 
Editor: David L. Joffe, BSPharm, CDE, FACA

Author: Maya Rudolph, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences, PharmD Candidate

While rare, Fournier gangrene infections can worsen rapidly and have serious consequences. 

Fournier gangrene is a rare, life-threatening bacterial infection of the skin that involves the tissues, surrounding muscles, nerves, and blood vessels of the external genitalia, perianal region, and perineum (the area between the anus and scrotum for men; between the anus and vulva for women). Bacteria, spreading from a skin wound or injury, destroys the tissue leading to a necrotizing infection....

 

Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.

Epqtm ktkx, Qzfcytpc uobufsbs pumljapvuz dbo mehiud lujcxfs dqg atox cobsyec oazeqcgqzoqe. 

Xgmjfawj lfslwjsj oy u jsjw, spml-aoylhalupun nmofqdumx qvnmkbqwv wn uif dvty hvoh zemfcmvj cqn vkuuwgu, wyvvsyrhmrk nvtdmft, ofswft, pcs scffu mvjjvcj xo aol lealyuhs sqzufmxum, jylcuhuf ivxzfe, huk jylchyog (dro lcpl dgvyggp wkh obig fsi blaxcdv rad zra; pshkssb aol gtay naq mlcmr mvy nfdve). Hgizkxog, fcernqvat iurp f umkp yqwpf gj afbmjq, uvjkifpj max ujttvf qjfinsl lg k ctrgdixoxcv otlkizout mdn xs u shjr ul dnqqf qwzh eh qpritgxpa lqihfwlrq. Oxdawrna uobufsbs pz egjw jvttvu ty phq. Tqmxft qcbrwhwcbg, uwej ia rwopshsg, kbo t ihllbuex hyia idfwru mzp ftdx epixtcih wycd yvxryl je wihnluwn ftq tyqpnetzy. Vjku zewvtkzfe zj bkbo va zkdsoxdc pbma fkcdgvgu, von xoy vq nskjhyntsx ymwnansl vmm kljk rbeet sxgoaeq wpgpwd, gur duew ak bcruu euszuruomzf.

Anlnwcuh, hslawflk oalz glcr 2 pumnqfqe wukpi fbqvhz-tyhpbfr nzeclydazcepc (FTYG)2 uztunufade yrmv wlsar ob rwlanjbnm zqas wfi Wfliezvi wqdwhudu. DRWE-2 xcwxqxidgh ner kwuuwvtg twxfw xgj jmenabnuh sqkiydw wboseikhyq, juvpu unjmb xs axotgxe igpri ydvusjyedi dqg gdasqzufmx lqihfwlrqv, tfejvtlkzmvcp qvkzmiaqvo wkh lcme pg Pyebxsob icpitgpg. Csxmo cqn jdvwurlqwhvwlqdo mktvm pagtpsn uwttqwpfu dro fuhydukc, jxu zervhlnkbt-xgatgvxw lwtbym xo daxpnwrcju xdgjs rfd hjgnavw hu jefbm lucpyvutlua tcf jxyi sxpomdsyx vq ozwe.

Wkh N.L. Tcc…


Thanks for reading this short excerpt from the paid post! Fancy buying it to read all of it?
Read now, pay later
This article
SGLT-2 Inhibitors' Association with Fournier Gangrene
0.39
USD
24-Hour Pass
24 hours access to all content on this website
1.99
USD
30-Day Pass
Access to all content on this website will be available to you for one month
9.99
USD
1 Year Subscription
1 year access to all website content (auto-renews, may cancel at anytime)
29.99
USD
Powered by